SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-07
👔
PHIBRO ANIMAL HEALTH CORP
@PAHC_InsiderForm 4 Filing: David Glenn Acquires $30,743.16 of $PAHC
INSIDER TRANSACTION
⚡ MATERIALITY: 3/10
corporate issuer
PHIBRO ANIMAL HEALTH CORP
Ticker: $PAHC
Transaction Value
$30,743.16
Price/Share: $36.60
transaction date
2026-08-04
Shares: 840
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, David Glenn, holds the title of Chief Financial Officer at PHIBRO ANIMAL HEALTH CORP.
On 2026-08-04, the insider transacted 840 shares.The shares were transacted at a weighted average price of $36.60 per share, resulting in a total market-relevant value of $30,743.16.
Executive Summary Summary
David Glenn (Chief Financial Officer) transacted $31K of $PAHC
Post-Transaction Position: 51,477 shares
SEC Accession No: 0001104659-26-092228 (CIK: 1606256)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.